SHS acquires stake in Single Use Support

SHS drew equity from its latest vehicle, SHS V Fonds, which held its first close in July 2018 on €90m. SHS expects to make 12-15 investments from the fund, committing a maximum of €30m per investment. The fund targets medical and diagnostic technology companies.

SHS intends to support the company's growth, including the development of its sales facilities, and to assist with its international expansion.

Unquote understands the deal was proactively sourced by the GP.

Company
Single Use Support is based in Kufstein, Austria, and has a headcount of 15. It was founded in 2015 by Johannes Kirchmair and Thomas Wurm.

The group produces single use bags for the transportation of liquids in the pharmaceuticals sector, including in frozen form. Its client base counts a number of pharmaceutical companies in Europe, Asia and the US.

People
Single Use Support – Johannes Kirchmair, Thomas Wurm (founders, managing directors).
SHS – Uwe Steinbacher (managing partner).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• Healthcare
• Expansion
• Austria